NLRP3 and graft versus host disease: Previous studies demonstrated that release of PAMPs and DAMPs upon tissue damage after conditioning treatment triggered synthesis of pro-IL-1β and activation of NLRP3 inflammasome respectively, leading to an promoted inflammatory response which impacts the development and severity of graft versus host disease (GVHD)36, 37.